Restricted accessResearch articleFirst published online 2021-01
A Global Profile of Reversible and Irreversible Cysteine Redox Post-Translational Modifications During Myocardial Ischemia/Reperfusion Injury and Antioxidant Intervention
Cysteine (Cys) is a major target for redox post-translational modifications (PTMs) that occur in response to changes in the cellular redox environment. We describe multiplexed, peptide-based enrichment and quantitative mass spectrometry (MS) applied to globally profile reversible redox Cys PTM in rat hearts during ischemia/reperfusion (I/R) in the presence or absence of an aminothiol antioxidant, N-2-mercaptopropionylglycine (MPG). Parallel fractionation also allowed identification of irreversibly oxidized Cys peptides (Cys-SO2H/SO3H).
Results:
We identified 4505 reversibly oxidized Cys peptides of which 1372 were significantly regulated by ischemia and/or I/R. An additional 219 peptides (247 sites) contained Cys-SO2H/Cys-SO3H modifications, and these were predominantly identified from hearts subjected to I/R (n = 168 peptides). Parallel reaction monitoring MS (PRM-MS) enabled relative quantitation of 34 irreversibly oxidized Cys peptides. MPG attenuated a large cluster of I/R-associated reversibly oxidized Cys peptides and irreversible Cys oxidation to less than nonischemic controls (n = 24 and 34 peptides, respectively). PRM-MS showed that Cys sites oxidized during ischemia and/or I/R and “protected” by MPG were largely mitochondrial, and were associated with antioxidant functions (peroxiredoxins 5 and 6) and metabolic processes, including glycolysis. Metabolomics revealed I/R induced changes in glycolytic intermediates that were reversed in the presence of MPG, which were consistent with irreversible PTM of triose phosphate isomerase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), altered GAPDH enzyme activity, and reduced I/R glycolytic payoff as evidenced by adenosine triphosphate and NADH levels.
Innovation:
Novel enrichment and PRM-MS approaches developed here enabled large-scale relative quantitation of Cys redox sites modified by reversible and irreversible PTM during I/R and antioxidant remediation.
Conclusions:
Cys sites identified here are targets of reactive oxygen species that can contribute to protein dysfunction and the pathogenesis of I/R.
Get full access to this article
View all access options for this article.
References
1.
AnastasiouD, PoulogiannisG, AsaraJM, BoxerMB, JiangJK, ShenM, BellingerG, SasakiAT, LocasaleJW, AuldDS, ThomasCJ, Vander HeidenMG, and CantleyLC. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science, 334: 1278–1283, 2011.
2.
BeckerLB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res, 61: 461–470, 2004.
3.
BeckerLB, Vanden HoekTL, ShaoZH, LiCQ, and SchumackerPT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol, 277: H2240–H2246, 1999.
4.
BiteauB, LabarreJ, and ToledanoMB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature, 425: 980–984, 2003.
5.
BolliR. Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”). J Am Coll Cardiol, 12: 239–249, 1988.
6.
BoronatS, DomènechA, and HidalgoE. Proteomic characterization of reversible thiol oxidations in proteomes and proteins. Antioxid Redox Signal, 26: 329–344, 2016.
7.
BrennanJP, WaitR, BegumS, BellJR, DunnMJ, and EatonP. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem. 279: 41352–41360, 2004.
8.
BroniowskaKA and HoggN. The chemical biology of S-nitrosothiols. Antioxid. Redox Signal, 17: 969–980, 2012.
9.
ChandelNS, MaltepeE, GoldwasserE, MathieuCE, SimonMC, and SchumackerPT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A, 95: 11715–11720, 1998.
10.
ChenYR, ChenCL, PfeifferDR, and ZweierJL. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem, 282: 32640–32654, 2007.
11.
ChenYR and ZweierJL. Cardiac mitochondria and reactive oxygen species generation. Circ Res, 114: 524–537, 2014.
12.
ChiversPT, LaboissièreMC, and RainesRT. The CXXC motif: imperatives for the formation of native disulfide bonds in the cell. EMBO J, 15: 2659–2667, 1996.
13.
ChouMF and SchwartzD. Biological sequence motif discovery using motif-x. Curr Protoc Bioinformatics, 13: 15–24, 2011.
DaviesMJ. Protein oxidation and peroxidation. Biochem J, 473: 805–825, 2016.
16.
DouliasPT, TenopoulouM, GreeneJL, RajuK, and IschiropoulosH. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci Signal, 6: rs1, 2013.
17.
EatonP, ByersHL, LeedsN, WardMA, and ShattockMJ. Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem, 277: 9806–9811, 2002.
18.
EdwardsAV, CordwellSJ, and WhiteMY. Phosphoproteomic profiling of the myocyte. Circ Cardiovasc Genet, 4: 575, 2011.
19.
Figueiredo-FreitasC, DulceRA, FosterMW, LiangJ, YamashitaAM, Lima-RosaFL, ThompsonJW, MoseleyMA, HareJM, NogueiraL, SorensonMM, and PintoJR. S-nitrosylation of sarcomeric proteins depresses myofilament Ca2+ sensitivity in intact cardiomyocytes. Antioxid Redox Signal, 23: 1017–1034, 2015.
20.
ForresterMT, ThompsonJW, FosterMW, NogueiraL, MoseleyMA, and StamlerJS. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol, 27: 557–559, 2009.
21.
GaoL, ZhengYJ, GuSS, TanJL, PaulC, WangYJ, and YangHT. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to contractile dysfunction during ischemia/reperfusion. J Mol Cell Cardiol, 77: 102–112, 2014.
22.
García-SantamarinaS, BoronatS, DomènechA, AytéJ, MolinaH, and HidalgoE. Monitoring in vivo reversible cysteine oxidation in proteins using ICAT and mass spectrometry. Nat Protoc, 9: 1131–1145, 2014.
23.
GoYM, ChandlerJD, and JonesDP. The cysteine proteome. Free Radic Biol Med, 84: 227–245, 2015.
24.
González-MondragónE, ZubillagaRA, SaavedraE, Chánez-CárdenasME, Pérez-MontfortR, and Hernández-AranaA. Conserved cysteine 126 in triosephosphate isomerase is required not for enzymatic activity but for proper folding and stability. Biochemistry, 43: 3255–3263, 2004.
25.
GouldN, DouliasPT, TenopoulouM, RajuK, and IschiropoulosH. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem, 288: 26473–26479, 2013.
26.
GrekCL, ZhangJ, ManevichY, TownsendDM, and TewKD. Causes and consequences of cysteine S-glutathionylation. J Biol Chem, 288: 26497–26504, 2013.
27.
GuoJ, NguyenAY, DaiZ, SuD, GaffreyMJ, MooreRJ, JacobsJM, MonroeME, SmithRD, KoppenaalDW, PakrasiHB, and QianWJ. Proteome-wide light/dark modulation of thiol oxidation in cyanobacteria revealed by quantitative site-specific redox proteomics. Mol Cell Proteomics, 13: 3270–3285, 2014.
28.
HuangH, PedersenMH, VeaMI, LassenPS, LarsenMR, and PalmisanoG. Simultaneous enrichment of cysteine-containing peptides and phosphopeptides using a cysteine-specific Phosphonate Adaptable Tag (CysPAT) in combination with TiO2 chromatography. Mol Cell Proteomics, 15: 3282–3296, 2016.
29.
IshiiT and UchidaK. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. Chem Res Toxicol, 17: 1313–1322, 2004.
30.
JaffreySR, Erdjument-BromageH, FerrisCD, TempstP, and SnyderSH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol, 3: 193–197, 2001.
31.
JonesSP, ZacharaNE, NgohGA, HillBG, TeshimaY, BhatnagarA, HartGW, and MarbánE. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation, 117: 1172–1182, 2008.
32.
KangPT, ChenC, LinP, ZhangL, ZweierJL, and ChenY. Mitochondrial complex I in the post-ischemic heart: reperfusion-mediated oxidative injury and protein cysteine sulfonation. J Mol Cell Cardiol, 121: 190–204, 2018.
33.
KlonerRA, EllisSG, LangeR, and BrunwaldE. Studies of experimental coronary artery reperfusion. Effects on infarct size, biochemistry, ultrastructure and microvascular damage. Circulation, 68: I8–I15, 1983.
34.
KohrMJ, AponteA, SunJ, GucekM, SteenbergenC, and MurphyE. Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags. Circ Res, 111: 1308–1312, 2012.
35.
KohrMJ, SunJ, AponteA, WangG, GucekM, MurphyE, and SteenbergenC. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res, 108: 418–426, 2011.
36.
KornfeldOS, HwangS, DisatnikMH, ChenCH, and Mochly-RosenD. Mitochondrial reactive oxygen species at the heart of the matter: new therapueitc approaches for cardiovascular diseases. Circ Res, 116: 1783–1799, 2015.
37.
KumarV, KleffmannT, HamptonMB, CannellMB, and WinterbournCC. Redox proteomics of thiol proteins in mouse heart during ischemia/reperfusion using ICAT reagents and mass spectrometry. Free Radic Biol Med, 58: 109–117, 2013.
38.
LabuggerR, OrganL, CollierC, AtarD, and Van EykJE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation, 102: 1221–1226, 2000.
39.
LeeJH, YangES, and ParkJW. Inactivation of NADP+-dependent isocitrate dehydrogenase by peroxynitrite. Implications for cytotoxicity and alcohol-induced liver injury. J Biol Chem, 278: 51360–51371, 2003.
40.
LeichertLI, GehrkeF, GudisevaHV, BlackwellT, IlbertM, WalkerAK, StrahlerJR, AndrewsPC, and JakobU. Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci U S A, 105: 8197–8202, 2008.
41.
Lo Conte M and CarrollKS. The redox biochemistry of protein sulfenylation and sulfinylation. J Biol Chem, 288: 26480–26488, 2013.
42.
MaJ, LiuT, WeiAC, BanerjeeP, O'RourkeB, and HartGW. O-GlcNAcomic profiling identifies widespread O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) in oxidative phosphorylation system regulating cardiac mitochondrial function. J Biol Chem, 290: 29141–29153, 2015.
43.
MaillouxRJ, JinX, and WillmoreWG. Redox regulation of mitochondrial function with an emphasis on cysteine oxidation reactions. Redox Biol, 2: 123–139, 2014.
44.
McDonoughJL, ArrellDK, and Van EykJE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res, 84: 9–20, 1999.
45.
MengG, ZhaoS, XieL, HanY, and JiY. Protein S-sulfhydration by hydrogen sulphide in cardiovascular system. Br J Pharmacol, 175: 1146–1156, 2018.
46.
MieyalJJ and ChockPB. Posttranslational modification of cysteine in redox signaling and oxidative stress: focus on S-glutathionylation. Antioxid Redox Signal, 16: 471–475, 2012.
47.
MohrS, StamlerJS, and BrüneB. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem, 271: 4209–4214, 1996.
48.
MurphyE, KohrM, SunJ, NguyenT, and SteenburgenC. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol, 52: 568–577, 2012.
49.
MurrayCI, KaneLA, UhrigshardtH, WangSB, and Van EykJE. Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics, 10: M110004721, 2011.
50.
MurrayCI, UhrigshardtH, O'MeallyRN, ColeRN, and Van EykJE. Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics, 11: M111.013441, 2012.
51.
MyersML, BolliR, LekichRF, HartleyCJ, and RobertsR. N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia. J Am Coll Cardiol, 8: 1161–1168, 1986.
52.
NadtochiySM, YaoH, McBurneyMW, GuW, GuarenteL, RahmanI, and BrookesPS. SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol, 301: H1506–H1512, 2011.
53.
PanKT, ChenYY, PuTH, ChaoYS, YangCY, BomgardenRD, RogersJC, MengTC, and KhooKH. Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia. Antioxid Redox Signal, 20: 1365–1381, 2014.
54.
ParkerBL, PalmisanoG, EdwardsAV, WhiteMY, Engholm-KellerK, LeeA, ScottNE, KolarichD, HamblyBD, PackerNH, LarsenMR, and CordwellSJ. Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Mol Cell Proteomics, 10: M110.006833, 2011.
55.
ParkerBL, ShepherdNE, TrefelyS, HoffmanNJ, WhiteMY, Engholm-KellerK, HamblyBD, LarsenMR, JamesDE, and CordwellSJ. Structural basis for phosphorylation and lysine acetylation cross-talk in a kinase motif associated with myocardial ischemia and cardioprotection. J Biol Chem, 289: 25890–25906, 2014.
56.
ParkerJ, BalmantK, ZhuF, ZhuN, and ChenS. CysTMTRAQ-an integrative method for unbiased thiol-based redox proteomics. Mol Cell Proteomics, 14: 237–242, 2015.
57.
PaulechJ, LiddyKA, Engholm-KellerK, WhiteMY, and CordwellSJ. Global analysis of myocardial peptides containing cysteines with irreversible sulfinic and sulfonic acid post-translational modifications. Mol Cell Proteomics, 14: 609–620, 2015.
58.
PaulechJ, SolisN, EdwardsAV, PuckeridgeM, WhiteMY, and CordwellSJ. Large-scale capture of peptides containing reversibly oxidized cysteines by thiol-disulfide exchange applied to the myocardial redox proteome. Anal Chem, 85: 3774–3780, 2013.
59.
PaulsenCE and CarrollKS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev, 113: 4633–4679, 2013.
60.
PellVR, ChouchaniET, FrezzaC, MurphyMP, and KreigT. Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. Cardiovasc Res, 111: 134–141, 2016.
61.
PooleLB. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med, 80: 148–157, 2015.
62.
PopovD. Protein S-glutathionylation: from current basics to targeted modifications. Arch Physiol Biochem, 120: 123–130, 2014.
63.
QuZ, MengF, BomgardenRD, VinerRI, LiJ, RogersJC, ChengJ, GreenliefCM, CuiJ, LubahnDB, Sun GY and GuZ. Proteomic quantification and site-mapping of S-nitrosylated proteins using isobaric iodoTMT reagents. J Proteome Res, 13: 3200–3211, 2014.
64.
Ramirez-CorreaGA, JinW, WangZ, ZhongX, GaoWD, DiasWB, VecoliC, Hart GW and MurphyAM. O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res, 103: 1354–1358, 2008.
65.
ReddyS, JonesAD, CrossCE, WongPS, and Van Der VlietA. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem J, 347: 821–827, 2000.
66.
RigboltKT, VanselowJT, and BlagoevB. GProX, a user-friendly platform for bioinformatics analysis and visualization of proteomics data. Mol Cell Proteomics, 10: O110.007450, 2011.
67.
RogersLK, LeinweberBL, and SmithCV. Detection of reversible protein thiol modifications in tissues. Anal Biochem, 358: 171–184, 2006.
68.
RomeroJM, CarrizoME, and CurtinoJA. Characterization of human triosephosphate isomerase S-nitrosylation. Nitric Oxide, 77: 26–34, 2018.
69.
SethuramanM, McCombME, HuangH, HuangS, HeibeckT, CostelloCE, and CohenRA. Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures. J. Proteome Res, 3: 1228–1233, 2004.
70.
ShahulHM and SarmaSP. The structure of the thioredoxin-triosephosphate isomerase complex provides insights into the reversible glutathione-mediated regulation of triosephosphate isomerase. Biochemistry, 51: 533–544, 2012.
71.
SharmaAB, SunJ, HowardLL, WilliamsAG Jr, and MalletRT. Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest. Am J Physiol Heart Circ Physiol, 292: H198–H206, 2007.
72.
SmythGE and ColmanRF. Cysteinyl peptides of pig heart NADP-dependent isocitrate dehydrogenase that are modified upon inactivation by N-ethylmaleimide. J Biol Chem, 266: 14918–14925, 1991.
73.
SuD, GaffreyMJ, GuoJ, HatchellKE, ChuRK, ClaussTR, AldrichJT, WuS, PurvineS, CampDG, SmithRD, ThrallBD, and QianWJ. Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling. Free Radic Biol Med, 67: 460–470, 2014.
74.
SuD, ShuklaAK, ChenB, KimJS, NakayasuE, QuY, AryalU, WeitzK, ClaussTR, MonroeME, CampDG2nd, BigelowDJ, SmithRD, KulkarniRN, and QianWJ. Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry. Free Radic Biol Med, 57: 68–78, 2013.
75.
SzklarczykD, FranceschiniA, WyderS, ForslundK, HellerD, Huerta-CepasJ, SimonovicM, RothA, SantosA, TsafouKP, KuhnM, BorkP, JensenLJ, and von MeringC. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 43: D447–D452, 2015.
76.
TakahashiI, TakasakiY, and HoriK. Site-directed mutagenesis of human aldolase isozymes: the role of Cys-72 and Cys-338 residues of aldolase A and of the carboxy-terminal Tyr residues of aldolases A and B. J Biochem, 105: 281–286, 1989.
77.
TalibJ, CookN, PattisonD, and DaviesMJ. Disruption of the iron-sulfur cluster of aconitase by myeloperoxidase-derived oxidants. Free Radic Biol Med, 75: S27–S28, 2014.
78.
TopfU, SuppanzI, SamlukL, WrobelL, BöserA, SakowskaP, KnappB, PietrzykMK, ChacinskaA, and WarscheidB. Quantitative proteomics identifies redox switches for global translation modulation by mitochondrially produced reactive oxygen species. Nat Commun, 9: 324, 2018.
79.
Vanden HoekTL, LiC, ShaoZ, SchumackerPT, and BeckerLB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol, 29: 2571–2583, 1997.
80.
WangD, FangC, ZongNC, LiemDA, CadeirasM, ScruggsSB, YuH, KimAK, YangP, DengM, LuH, and PingP. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics, 12: 3793–3802, 2013.
81.
WendtS, SchlattnerU, and WallimannT. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues. J Biol Chem, 278: 1125–1130, 2003.
82.
WhiteMY, BrownDA, ShengS, ColeRN, O'RourkeB, and Van EykJE. Parallel proteomics to improve coverage and confidence in the partially annotated Oryctolagus cuniculus mitochondrial proteome. Mol Cell Proteomics, 10: M110.004291, 2011.
83.
WhiteMY, CordwellSJ, McCarronHC, TchenAS, HamblyBD, and JeremyRW. Modifications of myosin-regulatory light chain correlate with function of stunned myocardium. J Mol Cell Cardiol, 35: 833–840, 2003.
84.
WhiteMY, HamblyBD, JeremyRW, and CordwellSJ. Ischemia-specific phosphorylation and myofilament translocation of heat shock protein 27 precedes alpha B-crystallin and occurs independently of reactive oxygen species in rabbit myocardium. J Mol Cell Cardiol, 40: 761–774, 2006.
85.
WhiteMY, TchenAS, McCarronHC, HamblyBD, JeremyRW, and CordwellSJ. Proteomics of ischemia and reperfusion injuries in rabbit myocardium with and without intervention by an oxygen free radical scavenger. Proteomics, 6: 6221–6233, 2006.
86.
WooHA, ChaeHZ, HwangSC, YangKS, KangSW, KimK, and RheeSG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science, 300: 653–656, 2003.
87.
YangJ, CarrollKS, and LieblerDC. The expanding landscape of the redox proteome. Mol Cell Proteomics, 15: 1–11, 2016.
88.
YangJ, GuptaV, CarrollKS, and LieblerDC. Site-sepcific mapping and quantification of protein S-sulphenation in cells. Nat Commun, 5: 4776, 2014.
89.
ZhangD, MacinkovicI, Devarie-BaezNO, PanJ, ParkCM, CarrollKS, FilipovicMR, and XianM. Detection of protein S-sulfhydration by a tag-switch technique. Angew Chem Int Ed Engl, 53: 575–581, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
